Featured today by @MSKLibrary: Evolution of the tumor immune landscape during treatment with tebentafusp, a T cell receptor-CD3 bispecific dx.doi.org/10.1016/j.xc...

#CancerImmunotherapy #TumorMicroenvironment
#ImmunoOncology #TCellTherapy #Tebentafusp #CD3Engager #ImmuneLandscape #Cancer

KIMMTRAK recommended for funding by NICE for uveal melanoma patients - PharmaTimes Immunocore has announced that Kimmtrak (tebentafusp) has been recommended for funding in England by the National Institute for Health and Care Excellence

#KIMMTRAK #tebentafusp #immunotherapy #biologics #NHSfunding #optics #Ophthalmology #Uvealmelanoma #eyecancer#Immunocore #TCR @england.nhs.uk #NICE #mUM #rarediseases #oncology #cancer #Tcellreceptorimmunotherapy #ImmTAC #ImmTACtechnologyplatform
pharmatimes.com/news/kimmtra...